Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was $14.72 for the day, down -2.77% from the previous closing price of $15.14. In other words, the price has decreased by -$2.77 from its previous closing price. On the day, 1.07 million shares were traded. CPRX stock price reached its highest trading level at $15.22 during the session, while it also had its lowest trading level at $14.53.
Ratios:
Our analysis of CPRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.68 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 14, 2024, initiated with a Buy rating and assigned the stock a target price of $27.
On March 07, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $23.
On December 21, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $30.Oppenheimer initiated its Outperform rating on December 21, 2023, with a $30 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 08 ’24 when Tierney David S sold 25,000 shares for $15.68 per share. The transaction valued at 392,000 led to the insider holds 348,874 shares of the business.
Elsbernd Brian sold 25,000 shares of CPRX for $411,000 on Mar 27 ’24. The Chief Compliance/Legal Officer now owns 124,433 shares after completing the transaction at $16.44 per share. On Dec 15 ’23, another insider, Harper Molly, who serves as the Director of the company, sold 14,000 shares for $14.39 each. As a result, the insider received 201,420 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CPRX now has a Market Capitalization of 1737121920 and an Enterprise Value of 1650370688. As of this moment, Catalyst’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.16, and their Forward P/E ratio for the next fiscal year is 9.45. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.36 while its Price-to-Book (P/B) ratio in mrq is 4.07. Its current Enterprise Value per Revenue stands at 4.145 whereas that against EBITDA is 13.788.
Stock Price History:
Over the past 52 weeks, CPRX has reached a high of $17.76, while it has fallen to a 52-week low of $11.09. The 50-Day Moving Average of the stock is -5.96%, while the 200-Day Moving Average is calculated to be 3.18%.
Shares Statistics:
CPRX traded an average of 1.33M shares per day over the past three months and 976140 shares per day over the past ten days. A total of 107.12M shares are outstanding, with a floating share count of 101.64M. Insiders hold about 13.76% of the company’s shares, while institutions hold 65.54% stake in the company. Shares short for CPRX as of 1713139200 were 6274288 with a Short Ratio of 4.72, compared to 1710460800 on 5825092. Therefore, it implies a Short% of Shares Outstanding of 6274288 and a Short% of Float of 6.61.
